Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other ... Regionally, developed Asia, which includes Japan, Hong Kong, Australia, South Korea, and ...

The pharmaceutical industry is key and needs to focus resources on promoting development to keep pace with modern medical ...

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold variety of use cases existing for digital twins, we can also include medical ...

Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing capabilities and ...

In this article, we are going to take a look at where Sanofi (NASDAQ ... South Korea, and Singapore – are expected to grow their dividends to $370.5 billion by the end of 2024, reflecting ...

Stocks like RITES, Patanjali Foods, National Fertilizers, Cyient, Awfis Space Solutions, IRIS Business Services, Torrent ...

In this article, we are going to take a look at where Sanofi (NASDAQ ... South Korea, and Singapore, is looking at a 3% rise in dividends this year. Europe, on the other hand, is expected to ...

The NSE Nifty 50 closed 19.75 points or 0.09% lower at 22,913.15, while the BSE Sensex ended 203.22 points or 0.27% down at ...

The FSHD Society, a leading nonprofit dedicated to advancing research and improving the lives of individuals with facioscapulohumeral muscular dystrophy (FSHD), proudly announces the appointment of ...

Novartis Singapore provided funding to Ipsos Pte Ltd Singapore for ... AstraZeneca, Kowa, Novartis, Pfizer, Sanofi and Regeneron. The remaining authors declare that the research was conducted in the ...

Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).